Dafna Capital Management LLC Cidara Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.77 - $3.84 $176,987 - $383,973	-99,993 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.25 - $2.35 $140,966 - $265,016	-112,773 Reduced 53.0%	99,993 $199,000
Q2 2018 Aug 13, 2018	BUY	$3.75 - $6.05 $711,127 - $1.15 Million	189,634 Added 819.79%	212,766 $1.11 Million
Q1 2018 May 15, 2018	SELL	$4.0 - $8.15 $773,084 - $1.58 Million	-193,271 Reduced 89.31%	23,132 $93,000
Q4 2017 Feb 14, 2018	BUY	$6.35 - $8.75 $50,450 - $69,518	7,945 Added 3.81%	216,403 $1.47 Million
Q3 2017 Nov 14, 2017	BUY	$5.75 - $8.1 $1.2 Million - $1.69 Million	208,458	208,458 $1.69 Million

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.